NCT05699577尚未招募不适用
Prognostic Value of Some Biochemical Markers in Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- serum level of Ca15-3
研究概览
简要总结
breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •female patients aged more than or equal 18 year diagnosed with breast cancer
- •metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not
排除标准
- •female patients less than 18 years patients having comorbid disease. patients with double malignancy
结局指标
主要结局
serum level of Ca15-3
时间窗: 6 months
Tumer marker
serum level of interferon gamma
时间窗: 6 months
Tumer marker
次要结局
未报告次要终点
研究者
Amany Fathy Abdelrasoul
demonestrator at medical biochemistry
Sohag University
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast CancerLymph Node MetastasisBreast CancerNCT06001528Shantou Central Hospital2,400
招募中
不适用
Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery ProtocolBreast Cancer FemaleBreast NeoplasmsBreast CancerNCT06624917University of Rome Tor Vergata110
进行中（未招募）
不适用
Predictive Clinical and Biological Parameters in Gynecological CancerEndometrium CancerCervix CancerOvarian CancerNCT01977274Institut Paoli-Calmettes300
已完成
不适用
Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian SamplesBreast CancerNCT05570266Nalagenetics Pte Ltd322
已完成
不适用
Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant TherapyBreast CancerNCT05519397Istanbul Training and Research Hospital56